Caris Life Sciences, Inc. (CAI)
28.30
-0.05
(-0.18%)
USD |
NASDAQ |
Oct 02, 16:00
28.44
+0.14
(+0.49%)
After-Hours: 20:00
Caris Life Sciences Profit Margin (Quarterly) : -0.24% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.24% |
| March 31, 2026 | -0.24% |
| December 31, 2025 | 27.98% |
| September 30, 2025 | 11.22% |
| June 30, 2025 | -39.58% |
| Date | Value |
|---|---|
| March 31, 2025 | -84.84% |
| December 31, 2024 | -28.44% |
| September 30, 2024 | -66.65% |
| June 30, 2024 | -66.15% |
| March 31, 2024 | -137.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CareDx, Inc. | 83.85% |
| Natera, Inc. | -8.90% |
| Myriad Genetics, Inc. | -22.65% |
| BioRestorative Therapies, Inc. | -9.29K% |
| Exagen, Inc. | -16.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.51% |
| Return on Assets | 9.63% |
| Return on Invested Capital | 10.84% |
| Gross Profit Margin (Quarterly) | 68.10% |
| Operating Margin (Quarterly) | 10.21% |
| Return on Net Operating Assets | 39.01% |